Can-Fite BioPharma Ltd. (CANF)
3.28
-0.05
(-1.50%)
USD |
NYAM |
Aug 24, 16:00
3.28
0.00 (0.00%)
After-Hours: 20:00
Can-Fite BioPharma Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.243M |
| September 30, 2023 | 5.235M |
| June 30, 2023 | 6.874M |
| March 31, 2023 | 8.493M |
| December 31, 2022 | 4.472M |
| September 30, 2022 | 7.428M |
| June 30, 2022 | 9.892M |
| March 31, 2022 | 12.02M |
| December 31, 2021 | 14.38M |
| September 30, 2021 | 9.334M |
| June 30, 2021 | 3.955M |
| March 31, 2021 | 7.078M |
| December 31, 2020 | 6.074M |
| September 30, 2020 | 9.541M |
| June 30, 2020 | 9.156M |
| March 31, 2020 | 5.069M |
| December 31, 2019 | 0.877M |
| September 30, 2019 | 7.056M |
| June 30, 2019 | 8.441M |
| March 31, 2019 | 3.245M |
| December 31, 2018 | 3.015M |
| September 30, 2018 | 6.387M |
| June 30, 2018 | 6.51M |
| March 31, 2018 | 7.429M |
| December 31, 2017 | 5.014M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.463M |
| June 30, 2017 | 4.015M |
| March 31, 2017 | 5.792M |
| December 31, 2016 | 3.863M |
| September 30, 2016 | 5.853M |
| June 30, 2016 | 7.732M |
| March 31, 2016 | 9.252M |
| December 31, 2015 | 10.35M |
| September 30, 2015 | 6.872M |
| June 30, 2015 | 4.697M |
| March 31, 2015 | 5.962M |
| December 31, 2014 | 6.486M |
| September 30, 2014 | 2.52M |
| June 30, 2014 | 4.085M |
| March 31, 2014 | 5.630M |
| December 31, 2013 | 3.810M |
| September 30, 2013 | 1.052M |
| June 30, 2013 | 0.6247M |
| March 31, 2013 | 1.685M |
| December 31, 2012 | -1.245M |
| September 30, 2012 | 0.4132M |
| June 30, 2012 | 1.939M |
| March 31, 2012 | 1.813M |
| December 31, 2011 | 2.695M |
| September 30, 2011 | 0.2637M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioLineRx Ltd. | 16.67M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 269.56M |
| Galmed Pharmaceuticals Ltd. | 13.95M |
| Revium Recovery, Inc. | 18.10M |